216 related articles for article (PubMed ID: 25582846)
1. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
[TBL] [Abstract][Full Text] [Related]
2. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
[TBL] [Abstract][Full Text] [Related]
3. Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.
Oni OA; Dehkordi SHH; Jazayeri MA; Sharma R; Sharma M; Masoomi R; Sharma R; Gupta K; Barua RS
Am J Cardiol; 2019 Oct; 124(8):1171-1178. PubMed ID: 31409450
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
[TBL] [Abstract][Full Text] [Related]
6. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic use and myocardial infarction in older patients with treated dementia.
Pariente A; Fourrier-Réglat A; Ducruet T; Farrington P; Béland SG; Dartigues JF; Moore N; Moride Y
Arch Intern Med; 2012 Apr; 172(8):648-53; discussion 654-5. PubMed ID: 22450214
[TBL] [Abstract][Full Text] [Related]
9. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
[TBL] [Abstract][Full Text] [Related]
10. Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational Research.
Li H; Mawanda F; Mitchell L; Zhang X; Goodloe R; Vincent M; Motsko S
Pharmaceut Med; 2022 Aug; 36(4):247-259. PubMed ID: 35788962
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
12. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
[TBL] [Abstract][Full Text] [Related]
13. Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis.
Lee JH; Shah PH; Uma D; Salvi DJ; Rabbani R; Hamid P
Cureus; 2021 Aug; 13(8):e17475. PubMed ID: 34513525
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
16. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
[TBL] [Abstract][Full Text] [Related]
17. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
18. Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.
Loeb S; Folkvaljon Y; Damber JE; Alukal J; Lambe M; Stattin P
J Clin Oncol; 2017 May; 35(13):1430-1436. PubMed ID: 28447913
[TBL] [Abstract][Full Text] [Related]
19. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort.
Carman WJ; Su S; Cook SF; Wurzelmann JI; McAfee A
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):754-62. PubMed ID: 21567652
[TBL] [Abstract][Full Text] [Related]
20. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL; Morgentaler A
Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]